0001824618-21-000002.txt : 20210909 0001824618-21-000002.hdr.sgml : 20210909 20210909111710 ACCESSION NUMBER: 0001824618-21-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210909 DATE AS OF CHANGE: 20210909 EFFECTIVENESS DATE: 20210909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cedilla Therapeutics, Inc. CENTRAL INDEX KEY: 0001824618 IRS NUMBER: 822647784 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-376252 FILM NUMBER: 211243858 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617- 281-5658 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0708 D/A LIVE 0001824618 Cedilla Therapeutics, Inc. 245 First Street CAMBRIDGE MA MASSACHUSETTS 02142 617- 281-5658 DELAWARE None None Corporation true 2017 Alexandra Glucksmann 245 First Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Eli Casdin 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Dominik Naczynski 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Abbie Celniker 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Neil Exter 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Rosana Kapeller 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Chris Bowden 245 First Street Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b true 0001824618-20-000001 2020-09-09 false true false 0 60000000 57599996 2400004 false 19 0 0 0 false Cedilla Therapeutics, Inc. /s/ Alexandra Glucksmann Alexandra Glucksmann President and Chief Executive Officer 2021-09-09